Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Spark Therapeutics’ eye drug succeeds in study

Drug developer Spark Therapeutics Inc said its lead experimental drug helped improve the vision of patients with a type of inherited eye disorder, in a late stage study. The drug, SPK-RPE65, met the main goal of improving vision and sensitivity to light in patients who were previously at the risk of complete blindness, the company […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom